Literature DB >> 22020174

Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma.

E Carreño1, M A Saornil, C Garcia-Alvarez, F Lopez-Lara, J M De Frutos-Baraja, A Almaraz.   

Abstract

PURPOSE: The aim of this study was to determine the prevalence of ocular and oculodermal melanocytosis (ODM) among patients with uveal melanoma (UM) in a Spanish population.
METHODS: Retrospective review of the medical records of patients with ODM among patients with UM.
RESULTS: Ten (11 eyes) of 400 patients (2.7%) with UM associated had ODM. The mean age at diagnosis of UM among patients with ODM was 62 years. One patient had bilateral tumours. UM was diagnosed during a routine-examination in two cases. All tumours were medium (7/11) or large (4/11) in size, with a mean maximum base of 13 mm and height of 7 mm. No patient had extraocular extension or metastatic disease at diagnosis. Enucleation was done in five cases and I-125-brachytherapy in six. The mean follow-up was 43 months. One patient died because of metastasis 2 years after enucleation; one patient is currently on treatment of systemic metastasis 11 years after.
CONCLUSIONS: ODM is more frequent in spanish population with UM than in American population. Despite the risk of UM in ODM, it is often diagnosed late when a conservative treatment is not indicated.

Entities:  

Mesh:

Year:  2011        PMID: 22020174      PMCID: PMC3259590          DOI: 10.1038/eye.2011.257

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  18 in total

1.  Ocular findings in oculodermal melanocytosis.

Authors:  C Teekhasaenee; R Ritch; U Rutnin; N Leelawongs
Journal:  Arch Ophthalmol       Date:  1990-08

2.  Scleral melanocytosis and oculodermal melanocytosis (nevus of Ota) in Chinese children.

Authors:  A K Leung; C P Kao; H Y Cho; M P Siu; M C Choi; R S Sauve
Journal:  J Pediatr       Date:  2000-10       Impact factor: 4.406

3.  Ocular and oculodermal melanocytosis.

Authors:  J R Gonder; J Nichol; J J Augsburger; J A Shields
Journal:  Can J Ophthalmol       Date:  1985-08       Impact factor: 1.882

4.  Iris melanoma arising from sector congenital ocular melanocytosis in a child.

Authors:  Jerry A Shields; Carol L Shields; Richard Davidson; Ralph C Eagle
Journal:  Cornea       Date:  2009-12       Impact factor: 2.651

5.  Ocular melanocytosis. A study to determine the prevalence rate of ocular melanocytosis.

Authors:  J R Gonder; P C Ezell; J A Shields; J J Augsburger
Journal:  Ophthalmology       Date:  1982-08       Impact factor: 12.079

6.  Uveal malignant melanoma associated with ocular and oculodermal melanocytosis.

Authors:  J R Gonder; J A Shields; D M Albert; J J Augsburger; P T Lavin
Journal:  Ophthalmology       Date:  1982-08       Impact factor: 12.079

7.  Ocular and oculodermal melanocytosis associated with uveal melanoma.

Authors:  N Velazquez; I S Jones
Journal:  Ophthalmology       Date:  1983-12       Impact factor: 12.079

8.  Histogenesis of malignant melanomas of the uvea. 3. The relationship of congenital ocular melanocytosis and neurofibromatosis in uveal melanomas.

Authors:  M Yanoff; L E Zimmerman
Journal:  Arch Ophthalmol       Date:  1967-03

9.  Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology.

Authors:  I W McLean; W D Foster; L E Zimmerman; J W Gamel
Journal:  Am J Ophthalmol       Date:  1983-10       Impact factor: 5.258

10.  Nevus of Ota associated with meningeal melanosis and intracranial melanoma. Case report.

Authors:  H J Sagar; E B Ilgren; C B Adams
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

View more
  2 in total

1.  GNAQ and PMS1 Mutations Associated with Uveal Melanoma, Ocular Surface Melanosis, and Nevus of Ota.

Authors:  Christopher B Toomey; Kyle Fraser; John A Thorson; Michael H Goldbaum; Jonathan H Lin
Journal:  Ocul Oncol Pathol       Date:  2019-01-10

2.  Ophthalmic associations of oculodermal melanocytosis in a tertiary eye hospital in South Asia.

Authors:  Bipul Kumer De Sarker; Mohammad Ibn Abdul Malek; Sadiq Abdullahi; Sazzad Iftekhar; Nazmus Sakeb; Mallika Mahatma; Mridul Kumar Sarkar
Journal:  Ther Adv Ophthalmol       Date:  2021-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.